All News

About a quarter of joints examined had at least 1 joint bleed.

Approximately one quarter of patients who have psoriasis experience disease onset before adulthood.

Jeffrey E. Lancet, MD, chair of the Department of Malignant Hematology at Moffitt Cancer Center, gave insight on the evolving treatment landscape of acute myeloid leukemia (AML) and the potential of immunotherapy and targeted therapies going forward.

Mark A. Socinski, MD, executive director of AdventHealth Cancer Institute, gave insight into treatment resistance and the importance of repeat biomarker testing at the time of disease progression in non–small cell lung cancer (NSCLC).

Neal Dave, PharmD, executive director of pharmacy operations at Texas Oncology, discusses updates to the National Community Oncology Dispensing Association (NCODA) Center of Excellence pharmacy accreditation program.

The 2023 Asembia Specialty Pharmacy Summit featured Juliana (Julie) Reed, executive director of the Biosimilars Forum, who spoke on the challenges still facing the biosimilars industry and how they may impact the success of adalimumab biosimilars in the United States.

The DEA desires to extend its COVID-19 prescription flexibilities; the Biden administration warns Americans to avoid medical credit cards; more US women are avoiding unwanted or ill-timed pregnancies, but a growing share of women over 35 say their pregnancies are coming later than desired.

A cross-sectional survey of patient preferences found that the out-of-pocket cost of treatment was the most impactful attribute for patients when choosing an androgen deprivation therapy (ADTs) for their prostate cancer.

Iptacopan elicited improved hemoglobin levels measuring at least 2 g/dL higher vs baseline, leading to transfusion independence after 24 weeks in approximately 92.2% of patients with complement inhibitor–naïve paroxysmal nocturnal hemoglobinuria.

Individuals with chronic obstructive pulmonary disease (COPD) experience improved breathing symptoms and dyspnea with use of automated oxygen administration.

Stephen M. Schleicher, MD, MBA, Tennessee Oncology, co-authored a recent paper on the complexities of the rural cancer experience; the principal conclusion was potential for a streamlined care process to optimize care efficiencies and access, thereby improving patient outcomes.

OneOncology now has partner practices in 14 states.

Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma are type 2 inflammatory conditions that frequently coexist, the with the latter increasing the symptom burden of the former

A panel at Asembia 2023 discussed what their organizations are doing to improve diversity, equity, and inclusion (DEI) at their organizations, and what others can learn from these efforts.

A vaccine for adults 60 years and older was approved by the FDA for protection against respiratory syncytial virus, making it the first such vaccine to be approved worldwide.

Further epidemiologic studies on nonpharmaceutical interventions are warranted to assess their relationship with respiratory syncytial virus (RSV).

Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with home administration.

When presented with a set of multiple choice questions used to help trainees practice for the ophthalmology board certification exams, the artificial intelligence (AI) chatbot ChatGPT was able to answer only half correctly.

The decline followed 3 months of growth from November 2022 to January 2023.

One dose of human papillomavirus vaccine (HPV) vaccine can prevent infection for at least 3 years, and maybe even longer; Eli Lilly plans to seek FDA approval for Alzheimer drug that slows decline; New York governor signed a bill expanding contraceptive access in the state next year.

Study investigators stress the importance of health care professionals familiarizing themselves with risk factors among a more diverse patient population.

Investigators said data show social factors are intertwined with health outcomes.

The authors of the study noted the importance of balancing resources available with efficient use of them and to use tailored tools so improve efficiency.

Although digital tools can be immensely helpful for creating a personalized, convenient interaction between patients and the health care system, they should not be the end-all be-all method to improve the patient experience, according to a panel discussion at the 2023 Asembia Specialty Pharmacy Summit.

The partnership will help develop standards for data transfer to eliminate manual steps used in clinical trials.

Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health, discusses what's to come as a result of a "second wave" of biosimilars hitting the market.

A patient’s inability to count while holding their breath can be an indication of respiratory distress in myasthenia gravis.

At the first business session of Asembia 2023, Ray Tancredi, divisional vice president at Walgreens, provided updates to the 2023 specialty therapy pipeline.

In a panel at the 2023 Asembia Specialty Pharmacy Summit, speakers presented on the payer perspective regarding biosimilars, including that they feel comfortable preferring multiple biosimilars for the same reference product and are looking for interchangeability designations.

Current cigarette and electronic nicotine delivery systems (ENDS) were associated with elevated wheezing, but not ENDS use alone, according to a new study.